CITN Staff

Cancer Immunotherapy Trials Network

CITN Staff

Betty Bertoldi

Betty Bertoldi is the Project Coordinator in the Cancer Immunotherapy Trials Network (CITN) at Fred Hutch. As the Project Coordinator, she is the administrative and operational liaison for the network.

Betty previously owned and operated a successful small business for many years, bringing entrepreneurial skills and understanding to an ever-changing environment as the CITN develops. While a business owner, she earned a Bachelor of Arts degree from Antioch University in organizational development with the goal of making a career transition into the health care industry. Her previous role was in another major network at the Hutch in administrative support.

Betty's previous experience includes roles demonstrating leadership, vision, creativity, and a solution-focused approach to problems. These skills help keep the coordinating center focused on quality, customer service, and high standards.

Contact: ebertold@fredhutch.org


Judith Kaiser, RN BSN CCRP

Ms. Kaiser is a Senior Vaccine Trials Project Manager in the Cancer Immunotherapy Trials Network (CITN) within the Vaccine and Infectious Disease Division at Fred Hutch. She has extensive research experience from both the clinical and sponsor perspective.

Prior to joining the CITN Ms. Kaiser was the Research Administrator of the Fred Hutch/UW Cancer Consortium Breast Cancer Research Program.

Her prior research experience includes Research Project Manager for a large, multicenter (90 sites), jointly funded (National Heart, Lung, and Blood Institute and industry), clinical trial from site selection and development of network infrastructure, through protocol implementation and study closeout. Her role also included extensive traveling to conduct study monitoring and regulatory reporting.

She worked within the Department of Medicine at the University of Washington as a Research Nurse for industry, NIH and Investigator Initiated trials for many years.

Currently she works with other members of the Network development team to design the infrastructure needed to develop and conduct novel protocols from initial concept to participant enrollment.

She is a key liaison between member sites, government agencies and industry partners providing single point-of-contact to identify and access CITN resources.

Contact: jckaiser@fredhutch.org


Andreanne Lacroix, B.Sc.

Andreanne is a Vaccine Trials Project Manager in the Cancer Immunotherapy Trials Network (CITN) within the Vaccine and Infectious Disease Division at Fred Hutch. She currently has oversight for protocol implementation at the CITN member sites and is the network Medidata project lead. Andreanne has a bachelor’s degree in pharmacology and professional experience as a clinical research assistant and project manager.

Her prior clinical research experience includes Project Manager/Data Coordinator for a large phase III, international, multicenter (90 sites) clinical trial from site selection, protocol implementation, data review and reconciliation, through study database lock. Her role also involved managing study medication inventory as well as on-site monitoring of clinical research sites.

Andreanne also worked in close collaboration with two nationwide research networks where she served as the primary liaison with clients. In this role, she oversaw and managed day-to-day operations while ensuring compliance with applicable federal regulations and corporate Standard Operating Procedures (SOPs).

As a vaccine trials project manager with the CITN, Andreanne ensures the efficient, effective implementation of the research protocols at study sites by facilitating communication between sites, other units within the CITN, and the Central Operations and Statistical Center (COSC).

Contact: amlacroi@fredhutch.org


Lisa Lundgren, M.S., R.PH.

Ms. Lundgren is a Senior Vaccine Trials Project Manager in the Cancer Immunotherapy Trials Network (CITN) within the Vaccine and Infectious Disease Division at Fred Hutch. She has substantial clinical research experience from the site perspective, industry background in medical information, and clinical pharmacy experience in hospital settings. Lisa has a B.S. in Pharmacy and a M.S. in Hospital Pharmacy Administration.

Prior to joining the CITN, Ms. Lundgren was the Research Manager for the Franciscan Health System in Tacoma, WA, where her team participated with local investigators in pharma- and device company sponsored studies in cardiology, cardiac surgery, interventional radiology, pulmonology, colorectal surgery and oncology.

While at Immunex Corporation, she provided medical information on an array of oncology products to health professionals, scientists and laypersons, and specialized in GM-CSF, the first FDA-approved hematopoietic growth factor for supporting reconstitution of white blood cell counts following autologous bone marrow transplantation.

She is the newest member of the CITN team and is working to develop and implement protocols for the Network.

Contact: llundgre@fredhutch.org


Richard Shine, PharmD, BCPS

Dr. Shine is a Senior Vaccine Trials Project Manager in the Cancer Immunotherapy Trials Network (CITN) within the Vaccine and Infectious Disease Division at Fred Hutch. Prior to joining the network he was the Program Director for the MultiCare Health System Institute for Research and Innovation in Tacoma Washington. He was responsible for the growth and development of the Institute beginning the program with 3 FTE’s in 2003 culminating with 33 FTE’s in 2013 including a Medical Director and a Grants Office.

He managed the Northwest Community Clinical Oncology Program (NW CCOP) from 2005 through 2013. The NW CCOP is an NCI funded community oncology research program with affiliate sites throughout the Pacific Northwest. In 2013 the program was in its 30th year of continuous funding. He served as the research pharmacist for the NW CCOP from 1983 to 2003 and served as a member of the Gynecologic Oncology Group Developmental Therapeutics committee for a number of years. He chaired the Institutional Review Board at MultiCare Health System for ten years.

Dr. Shine has an extensive and varied clinical background. He helped to implement the decentralized clinical pharmacy services within MultiCare Health System. In 1995 he implemented clinical pharmacy services within the Medical Oncology Program at MultiCare. He obtained his Bachelor’s Degree in Pharmacy from Washington State University and his Doctor of Pharmacy Degree from the University of Washington. He is a Board Certified Pharmacotherapy Specialist through the Board of Pharmaceutical Specialties.

Contact: rshine@fredhutch.org


Denelle Reilly, JD

Denelle joined the CITN in 2013 as a Regulatory Affairs Associate. Denelle is responsible for facilitating the negotiations of CITN contracts and agreements. She also coordinates the CITN's submissions to the Central/Lead IRB located at the Fred Hutch. Researchers and collaborators are invited to contact Denelle at any time with questions about either of these areas.

Denelle has experience in providing regulatory guidance in clinical trials. Prior to joining the CITN, Denelle was the IRB Operations Manager for the Fred Hutch, which has IRBs overseeing the oncology trials for the Cancer Consortium (University of Washington, Seattle Children's, and the Seattle Cancer Care Alliance). She also worked as a Regulatory Analyst/Counsel at Western Institutional Review Board and served as a regulatory advisor to the NCI's Central IRBs (pediatric and adult).

Denelle has a law degree from Seattle University School of Law. When she is not working with the CITN, Denelle also works as a Regulatory Affairs Associate for the HIV Vaccine Trials Network (HVTN).

Contact: dreilly@fredhutch.org


Kiley Keelin

Kiley joined the CITN in May 2014 as a Regulatory Affairs Associate. Kiley is primarily responsibile for coordinating the CITN's submissions to the Central/Lead IRB located at the Fred Hutch.

Prior to joining the CITN, Kiley worked for the Institutional Review Board at the Children's Hospital of Philadelphia, where she gained experience in providing regulatory guidance in clinical trials.

Kiley has a B.A. from Johns Hopkins University and is finishing her M.S. in Clinical Research Organization and Management through Drexel College of Medicine. When Kiley is not working with the CITN, she works as a Regulatory Affairs Associate for the HIV Vaccine Trials Network (HVTN).

Contact: kkeelin@fredhutch.org